{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:23:07Z","timestamp":1777922587368,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>\n                    Extended-spectrum \u03b2-lactamase (ESBL)-producing isolates of\n                    <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                    have been increasingly recognized in the hospital settings in Iran as well as throughout the world. The aim of this study was to detect and determine the genes encoding the ESBLs including\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM<\/jats:sub>\n                    ,\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV<\/jats:sub>\n                    , and\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M<\/jats:sub>\n                    groups among the\n                    <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                    isolates at Labbafinejad Hospital by polymerase chain reaction (PCR) and characterize them by direct sequencing of PCR products. Eighty-nine isolates were isolated from patients at different wards during March 2008\u2013March 2009. They were identified as\n                    <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                    using biochemical tests. Susceptibility of isolates to 17 different antimicrobial agents was determined using agar disk diffusion method. The phenotypic confirmatory test was used to screen the isolates for production of ESBLs. To amplify the\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV<\/jats:sub>\n                    the template DNA was extracted by boiling method. Plasmid DNA was extracted using minipreparation kit and used as template in PCR for detection of\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM<\/jats:sub>\n                    and\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M<\/jats:sub>\n                    . The selected PCR products were sequenced and analyzed. All 89 strains were susceptible to imipenem. The rates of resistance to different antibiotics were in the following order: aztronam (79.7%), cefexime (67.4%), cefpodoxime (66.2%), cefotaxime (65.1%), ceftazidime (61.7%). The phenotypic confirmatory test detected 62 isolates (69.7%) as ESBL-producing\n                    <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                    . The prevalence of genes encoding ESBLs were as follows:\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM<\/jats:sub>\n                    54% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u200948),\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV<\/jats:sub>\n                    67.4% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u200960),\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-I<\/jats:sub>\n                    46.51% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u200940), and\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-III<\/jats:sub>\n                    29% (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    \u2009=\u200925). The\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-II<\/jats:sub>\n                    and\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-IV<\/jats:sub>\n                    were not detected. All\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM<\/jats:sub>\n                    types were characterized as\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM-1<\/jats:sub>\n                    and all\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-I<\/jats:sub>\n                    were identified as\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-15<\/jats:sub>\n                    . The SHV types were characterized as SHV-5, SHV-11, and SHV-12. The rate of ESBL at Labbafinejad Hospital was 25% increase in a 4-year study that ended in March 2009. It appears that\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>TEM-1<\/jats:sub>\n                    ,\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV-5<\/jats:sub>\n                    ,\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV-11<\/jats:sub>\n                    ,\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>SHV-12<\/jats:sub>\n                    , and\n                    <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                    <jats:sub>CTX-M-15<\/jats:sub>\n                    are the dominant ESBLs among the resistant strains of\n                    <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                    in Iran.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2009.0096","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T10:33:17Z","timestamp":1260181997000},"page":"49-53","source":"Crossref","is-referenced-by-count":100,"title":["Distribution of\n                    <i>bla<\/i>\n                    <sub>TEM<\/sub>\n                    ,\n                    <i>bla<\/i>\n                    <sub>SHV<\/sub>\n                    ,\n                    <i>bla<\/i>\n                    <sub>CTX-M<\/sub>\n                    Genes Among Clinical Isolates of\n                    <i>Klebsiella pneumoniae<\/i>\n                    at Labbafinejad Hospital, Tehran, Iran"],"prefix":"10.1177","volume":"16","author":[{"given":"Mohammad Mehdi","family":"Feizabadi","sequence":"first","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Delfani","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Raji","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araz","family":"Majnooni","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Aligholi","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Shahcheraghi","sequence":"additional","affiliation":[{"name":"Pasteur Institute of Iran","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Parvin","sequence":"additional","affiliation":[{"name":"Shahid Beheshti University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davud","family":"Yadegarinia","sequence":"additional","affiliation":[{"name":"Shahid Beheshti University of Medical Sciences","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,3]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0256-4947.55306","article-title":"Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia","volume":"29","author":"Al-Agamy M.H.","year":"2009","unstructured":"Al-Agamy M.H., , Shib A.M., , Tawfik A.F. 2009. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann. Saudi Med., 29:253\u2013257.","journal-title":"Ann. Saudi Med."},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000109587","article-title":"Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates","volume":"17","author":"Al-Zarouni M.","year":"2008","unstructured":"Al-Zarouni M., , Senok A., , Rashid F., , Al-Jesmi S.M., , Panigrahi D. 2008. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med. Princ. Pract., 17:32\u201336.","journal-title":"Med. Princ. Pract."},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1128\/AAC.01431-06","article-title":"Extended-spectrum \u03b2-lactamases producing Enterobacteriaceae strains in various types of private health care centers","volume":"51","author":"Arpin C.","year":"2007","unstructured":"Arpin C., , Coulange L., , Dubois V., , Andr\u00e9 C., , Fischer I., , Fourmaux S. et al. 2007. Extended-spectrum \u03b2-lactamases producing Enterobacteriaceae strains in various types of private health care centers. Antimicrob. Agents Chemother., 51:3440\u20133444.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/AAC.44.8.2230-2230.2000","article-title":"Are SHV beta-lactamases universal in Klebsiella pneumoniae?","volume":"44","author":"Babini G.S.","year":"2000","unstructured":"Babini G.S., , Livermore D.M. 2000. Are SHV beta-lactamases universal in Klebsiella pneumoniae? Antimicrob. Agents Chemother., 44:2230.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01672-07"},{"key":"e_1_3_3_8_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M2\/A7","author":"[CLSI] Clinical and Laboratory Standards Institute","year":"2002","unstructured":"[CLSI] Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved Standard M2\/A7. CLSI: Wayne, 2002."},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"pii19044","DOI":"10.2807\/ese.13.47.19044-en","article-title":"Increasing prevalence of ESBL- producing Enterobacteriaceae in Europe","volume":"13","author":"Coque T.M.","year":"2008","unstructured":"Coque T.M., , Buquero F., , Canton R. 2008. Increasing prevalence of ESBL- producing Enterobacteriaceae in Europe. Euro Surveill., 13:pii19044.","journal-title":"Euro Surveill."},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/jac\/dkn287","article-title":"Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamases producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new MRSAs?","volume":"62","author":"Damjanova IToth A.","year":"2008","unstructured":"Damjanova IToth A., , Paszti J., , Hajbel-Vekony G., , Jakab M., , Berta J., , Milch H. et al. 2008. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamases producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new MRSAs? J. Antimicrob. Chemother., 62:978\u2013985.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_3_11_2","first-page":"362","article-title":"Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran","volume":"12","author":"Feizabadi M.M.","year":"2006","unstructured":"Feizabadi M.M., , Etemadi G., , Yadegarinia D., , Rahmati M., , Shabanpoor S., , Bokaei S. 2006. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med. Sci. Monit., 12:362\u2013365.","journal-title":"Med. Sci. Monit."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210973"},{"key":"e_1_3_3_13_2","first-page":"401","article-title":"Extended-spectrum \u03b2-lactamases: implications for the clinical laboratory and therapy","volume":"28","author":"Harada S.","year":"2008","unstructured":"Harada S., , Ishii Y., , Yamaguchi K. 2008. Extended-spectrum \u03b2-lactamases: implications for the clinical laboratory and therapy. Korean J. Lab Med., 28:401\u2013412.","journal-title":"Korean J. Lab Med."},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.49.5.2122-2125.2005","article-title":"Spanish Group for Nosocomial Infections. Nationwide study of Esherichia coli and Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases in Spain","volume":"49","author":"Hernandez J.R.","year":"2005","unstructured":"Hernandez J.R., , Martinez-Martinez L., , Canton R., , Coque T.M., , Pascual A. 2005. Spanish Group for Nosocomial Infections. Nationwide study of Esherichia coli and Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases in Spain. Antimicrob. Agents Chemother., 49:2122\u20132125.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_15_2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","article-title":"More extended-spectrum \u03b2-lactamases","volume":"35","author":"Jacoby G.A.","year":"1991","unstructured":"Jacoby G.A., , Medeiros A.A. 1991. More extended-spectrum \u03b2-lactamases. Antimicrob. Agents Chemother., 35:1697\u20131704.","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.diagmicrobio.2007.06.016","article-title":"Turkish MISTIC Study Group. Antibiotic resistance surveillance over 4-year period (200-20003) in Turkey: results of the MISTIC program","volume":"59","author":"Korten V.","year":"2007","unstructured":"Korten V., , Ulusoy S., , Zarakolu P., , Mete B. 2007. Turkish MISTIC Study Group. Antibiotic resistance surveillance over 4-year period (200-20003) in Turkey: results of the MISTIC program. Diagn. Microbiol. Infect. Dis., 59:453\u2013457.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl483"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0463.2008.00922.x","article-title":"The first major extended-spectrum \u03b2-lactamases outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15","volume":"116","author":"Lytsy B.","year":"2008","unstructured":"Lytsy B., , Sandegren L., , Tano E., , Torell E., , Andersson D.I., , Melhus A. 2008. The first major extended-spectrum \u03b2-lactamases outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS, 116:302\u2013308.","journal-title":"APMIS"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm381"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2008.0814"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2007.00722.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/JCM.43.7.3309-3313.2005","article-title":"Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon","volume":"43","author":"Moubareck C.","year":"2005","unstructured":"Moubareck C., , Daoud Z., , Hakim\u00e9 N.I., , Hamz\u00e9 M., , Mangeney N., , Matta H. et al. 2005. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J. Clin. Microbiol., 43:3309\u20133313.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365540601105731","article-title":"The Finish Study Group for antimicrobial resistance, detection and molecular genetics of extendedspectrum \u03b2-lactamases among cefuroxime-resistant Esherichia coli and Klebsiella spp. isolates from Finland, 2002\u20132004","volume":"39","author":"Nyberg S.D.","year":"2007","unstructured":"Nyberg S.D., , Osterblad M., , Hakanen A.J., , Huovinen P., , Jalava J. 2007. The Finish Study Group for antimicrobial resistance, detection and molecular genetics of extendedspectrum \u03b2-lactamases among cefuroxime-resistant Esherichia coli and Klebsiella spp. isolates from Finland, 2002\u20132004. Scand. J. Infect. Dis., 39:417\u2013424.","journal-title":"Scand. J. Infect. Dis."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1128\/JCM.42.12.5715-5721.2004","article-title":"Phenotypic and molecular detection of CTX-M-lactamases produced by Escherichia coli and Klebsiella spp","volume":"42","author":"Pitout J.D.D.","year":"2004","unstructured":"Pitout J.D.D., , Hossain A., , Hanson N.D. 2004. Phenotypic and molecular detection of CTX-M-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol., 42:5715\u20135721.","journal-title":"J. Clin. Microbiol."},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.14.1233"},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1469-0691.2007.01867.x","article-title":"The spread of CTX-M-type extended-spectrum \u03b2-lactamases","volume":"14","author":"Rossolini G.M.","year":"2008","unstructured":"Rossolini G.M., , D'Andrea M.M., , Mugnaioli C. 2008. The spread of CTX-M-type extended-spectrum \u03b2-lactamases. Clin. Microbiol. Infect., 14,S:S33\u2013S41.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_3_28_2","first-page":"187","article-title":"Prevalence of extended-spectrum beta-lactamase in nosocomial and outpatients (ambulatory)","volume":"19","author":"Shah A.A.","year":"2004","unstructured":"Shah A.A., , Hasan F., , Ahmad S., , Ahmad A. 2004. Prevalence of extended-spectrum beta-lactamase in nosocomial and outpatients (ambulatory) Pak. J. Med. Sci., 19:187\u2013191.","journal-title":"Pak. J. Med. Sci."},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/0896034984","volume-title":"Molecular Bacteriology and Clinical Application","author":"Woodford N.","year":"1998","unstructured":"Woodford N., , Johnson A.P. 1998. Molecular Bacteriology and Clinical Application. Humana Press: Totowa, New Jersey, 17\u201333."},{"key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/dkh045","article-title":"Detection of TEM-52 in Salmonella enteric serovar Enteritidis in Scotland","volume":"53","author":"Yates C.M.","year":"2004","unstructured":"Yates C.M., , Brown D.J., , Edwards G.F., , Amyes S.G. 2004. Detection of TEM-52 in Salmonella enteric serovar Enteritidis in Scotland. J. Antimicrob. Chemother., 53:407\u2013408.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jac\/dkn181","article-title":"Turkey: a further country concerned by community-acquired of Esherichia coli clone 025-ST131producing CTX-M-15","volume":"62","author":"Yumuk Z.","year":"2008","unstructured":"Yumuk Z., , Afacan G., , Nicolas-Chanoine M.H., , Sotto A., , Lavigne J.P. 2008. Turkey: a further country concerned by community-acquired of Esherichia coli clone 025-ST131producing CTX-M-15. J. Antimicrob. Chemother., 62:284\u2013288.","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2009.0096","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2009.0096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2009.0096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:25:07Z","timestamp":1777667107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2009.0096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1089\/mdr.2009.0096"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2009.0096","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}